Literature DB >> 12050854

[Mechanisms of interaction between adenosine receptor subtypes on hippocampal serotonin release].

Motohiro Okada1, Gang Zhu, Shukuko Yoshida, Hiroto Iwasa, Sunao Kaneko.   

Abstract

To clarify the mechanisms of interaction between adenosine receptor subtypes (A1R and A2R) on 5-HT release, the present study determined the effects of adenosine receptor subtypes on voltage-sensitive Ca(2+)-channels (VSCCs), protein-kinases (PKs) and synaptic-proteins (SNAREs) related 5-HT release using microdialysis in freely moving rat. A1R-antagonists increased basal 5-HT release, which was reduced by inhibitors of N-VSCC, PKC and syntaxin predominantly, and by inhibitors of PKA and synaptobrevin weakly, but was not affected by P-VSCC inhibitor. In the presence of A1R-antagonist, A2R-agonists increased basal 5-HT release, whose action was inhibited by P-VSCC, PKA and synaptobrevin inhibitors predominantly and reduced by N-VSCC, PKC and syntaxin inhibitors weakly. Under the condition of adenylate-cyclase activation in the absence of A1R-antagonists, A2R-agonists increased basal 5-HT release. K(+)-evoked 5-HT release was enhanced by A1R-antagonist and A2R-agonist, whose actions were inhibited by P-VSCC, PKA and synaptobrevin inhibitors predominantly. These results suggest that an activation of A1R suppresses 5-HT release via an inhibition of N-VSCC/PKC/syntaxin and P-VSCC/PKA/synaptobrevin, and an activation of A2-R stimulates 5-HT release via an enhancement of P-VSCC/PKA/synaptobrevin. Therefore PKA activity plays an important role in the interaction between A1R and A2R on hippocampal 5-HT release.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12050854

Source DB:  PubMed          Journal:  Nihon Shinkei Seishin Yakurigaku Zasshi        ISSN: 1340-2544


  3 in total

1.  DPCPX, a selective adenosine A1 receptor antagonist, enhances the antidepressant-like effects of imipramine, escitalopram, and reboxetine in mice behavioral tests.

Authors:  Aleksandra Szopa; Ewa Poleszak; Karolina Bogatko; Elżbieta Wyska; Sylwia Wośko; Urszula Doboszewska; Katarzyna Świąder; Aleksandra Wlaź; Jarosław Dudka; Andrzej Wróbel; Piotr Wlaź; Anna Serefko
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-08-09       Impact factor: 3.000

2.  Caffeine enhances the antidepressant-like activity of common antidepressant drugs in the forced swim test in mice.

Authors:  Aleksandra Szopa; Ewa Poleszak; Elżbieta Wyska; Anna Serefko; Sylwia Wośko; Aleksandra Wlaź; Mateusz Pieróg; Andrzej Wróbel; Piotr Wlaź
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-11-27       Impact factor: 3.000

3.  8-Cyclopentyl-1,3-dimethylxanthine enhances effectiveness of antidepressant in behavioral tests and modulates redox balance in the cerebral cortex of mice.

Authors:  Mariola Herbet; Aleksandra Szopa; Anna Serefko; Sylwia Wośko; Monika Gawrońska-Grzywacz; Magdalena Izdebska; Iwona Piątkowska-Chmiel; Paulina Betiuk; Ewa Poleszak; Jarosław Dudka
Journal:  Saudi Pharm J       Date:  2018-02-08       Impact factor: 4.330

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.